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Lampiran 3. Hasil Analisis 
 
 
 Case Processing Summary 
 Pemberian  
Melatonin 
Cases 
 Missing Total 
N Percent N Percent N Percent 
Jumlah 
Leukosit 
Kontrol 6 100.0% 0 0.0% 6 100.0% 
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11.1500 6 2.20431 .89991
13.2167 6 2.44820 .99947
13.2167 6 2.44820 .99947
14.5000 6 2.47710 1.01127
11.1500 6 2.20431 .89991
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Std.  Dev iation
Std.  Error Mean
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95% Conf idence Interv al
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10.5833 6 2.46042 1.00446
9.7167 6 2.04589 .83523
9.7167 6 2.04589 .83523
10.4167 6 2.30253 .94001
10.5833 6 2.46042 1.00446
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6 11.1500 2.20431 .89991




















Levene's Test f or





Std.  Error Dif ference
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Upper
95% Conf idence Interv al
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6 13.2167 2.44820 .99947



































Levene's Test f or





Std.  Error Dif ference
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6 14.5000 2.47710 1.01127
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Shapiro-Wilk
Lillief ors Signif icance Correctiona. 
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Not corrected f or ties.a. 
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